Trial reportPloS one2026
Evolution of intraocular pressure after cataract surgery in nonglaucomatous patients: A post-hoc analysis of PERCEPOLIS clinical trial data.
Trial report in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIntraocular pressure (IOP) drops after cataract surgery, including in nonglaucomatous eyes, but the mechanisms and factors determining this change remain unclear. Thus, post-hoc analysis was conducted on PERCEPOLIS, a large randomized-controlled trial showing non-inferior endothelial-cell loss between two cataract-extraction techniques in nonglaucomatous eyes.
methodsEyes with preoperative and 1-, 3-, and 12-month IOP measurements were identified. None received IOP-lowering medication before or after surgery. To identify possible mechanisms driving postoperative IOP drop, the cohort was categorized according to preoperative IOP (High: 20-29; Intermediate: 15-19; Low: 10-14 mmHg). IOP change in the whole cohort and three subgroups was determined. Multivariable analysis assessed whether age, sex, cataract density, preoperative IOP, anterior-chamber depth, axial length, lens thickness, lens position, relative lens position, cataract-extraction method, effective phaco time, or implant power predicted IOP drop at 3 months in the whole cohort and each subgroup. The literature was reviewed to determine the influence of regression-to-the-mean, a misleading statistical phenomenon, on postoperative IOP drop.
resultsWhole-cohort IOP dropped from 17.6 ± 3.5 mmHg by 1.9 ± 0.2 (1 month), 2.4 ± 0.2 (3 months), and 1.7 ± 0.2 (12 months) mmHg. IOP drop was greatest in the High subgroup. Preoperative IOP predicted 3-month IOP change in the whole cohort (beta = 0.53 ± 0.04, p < 0.001) and all subgroups (range: beta = 0.36-0.72 ± 0.15-0.30, p = 0.0505-0.001). Male sex also predicted larger whole-cohort IOP drop (beta = 0.79, p = 0.01). Different variables predicted greater IOP change in the three subgroups: male sex in High (beta = 1.63 ± 0.57, p = 0.005), higher implant power in Intermediate (beta = 0.19 ± 0.07, p = 0.01), and hard cataract in Low (beta = 2.14 ± 0.89, p = 0.02). Literature review suggested that regression-to-the-mean accounts for only a small proportion of IOP drop after cataract surgery.
conclusionsThe IOP drop after cataract surgery may largely be a real biological effect. In normotensive eyes, the strongest predictor of postoperative IOP drop was preoperative IOP. Distinct mechanisms may mediate the IOP change in normotensive eyes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.